| Revista: | Gaceta médica de Caracas |
| Base de datos: | |
| Número de sistema: | 000596120 |
| ISSN: | 2739-0012 |
| Autores: | Amir, Muzakkir1 Djaharuddin, Irawaty2 Saputri, Siti Ayu2 Qanitha, Andriany3 |
| Instituciones: | 1Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Hasanuddin, Makassar 90245, Indonesia, 2Department of Pulmonology and Respirology Medicine, Faculty of Medicine, Universitas Hasanuddin, Makassar 90245, Indonesia, 3Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Hasanuddin, Makassar 90245, Indonesia. Department of Physiology, Faculty of Medicine, Universitas Hasanuddin, Makassar 90245, Indonesia. Doctoral Study Program, Faculty of Medicine, Universitas Hasanuddin, Makassar 90245, Indonesia, |
| Año: | 2024 |
| Volumen: | 132 |
| Número: | 3 |
| Paginación: | 772-784 |
| País: | Venezuela |
| Idioma: | Español |
| Resumen en español | Cardiotoxicity is one of the most relevant complications associated with the use of chemotherapeutic agents due to their adverse effects on a patients prognosis and quality of life. This review aimed to capture the clinical profile of patients with advanced lung cancer with chemotherapy, as well as to summarize the type, risk factors, incidence, management, and outcomes of chemotherapy-related cardiotoxicity. From systematic searching, we included ten articles. The mean age of all case reports was 60.1 ± 6.9 years, and 90% of cases were male. The majority (60%) of lung cancer reported in this review was non-small cell carcinoma (NSCC). |
| Palabras clave: | Lung cancer, chemotherapy, cardiotoxicity |
| Texto completo: | Texto completo (Ver PDF) Texto completo (Ver HTML) |
